TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.

Caio Max Sao Pedro Rocha Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.